THYROCARE TECH LTD (THYROCARE) financials

THYROCARE TECH LTD (THYROCARE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Market Cap: ₹7,852Cr.
Current Price: ₹494
Stock P/E: 47.0
ROE: 26.8%
ROCE: 36.1%
Book Value: ₹35.2
Dividend Yield: 1.89%
52W High / Low: ₹662/343

In Jun 2026, THYROCARE TECH LTD (THYROCARE) reported sales ₹226 Cr and net profit ₹50 Cr.

Annual TTM: sales ₹821 Cr, net profit ₹163 Cr.

Shareholding: Promoters 51.02% (Sep 2026), FIIs 9.37% (Sep 2026), DIIs 25.92% (Sep 2026), Public 13.69% (Sep 2026), No. of Shareholders 75,186% (Sep 2026).

THYROCARE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	163	153	174	179	202	182	211	226
Expenses	114	112	118	122	133	124	138	150
Operating Profit	49	40	56	57	69	58	73	76
OPM %	30%	26%	32%	32%	34%	32%	34%	34%
Other Income	2	4	5	4	2	-3	4	4
Interest	1	0	1	1	1	-0	1	1
Depreciation	10	15	12	9	10	20	13	11
Profit before tax	40	28	48	51	61	37	62	67
Tax %	27%	32%	54%	29%	29%	29%	30%	25%
Net Profit	30	19	22	36	43	26	44	50
EPS in Rs	1.86	1.20	1.38	2.27	2.71	1.64	2.74	3.15
Raw PDF	—	—	—	—	—	—	—	—

THYROCARE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	401	474	562	486	524	633	774	821
Expenses	233	304	330	371	388	446	517	546
Operating Profit	168	171	232	115	136	188	257	275
OPM %	42%	36%	41%	24%	26%	30%	33%	34%
Other Income	-35	12	7	5	6	13	7	7
Interest	1	1	3	5	5	3	3	3
Depreciation	20	21	28	34	39	47	51	53
Profit before tax	112	161	207	81	98	151	210	226
Tax %	29%	26%	27%	30%	28%	37%	29%	—
Net Profit	79	120	152	57	71	96	149	163
EPS in Rs	5.00	7.55	9.58	3.59	4.48	6.02	9.35	10.24
Dividend Payout %	33%	110%	52%	167%	134%	116%	150%	—

THYROCARE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	53	53	53	53	53	53	53	159
Reserves	403	325	393	468	468	461	484	402
Borrowings	0	9	10	21	21	39	23	48
Other Liabilities	32	55	73	55	70	68	116	102
Total Liabilities	488	442	528	597	612	620	676	711
Fixed Assets	108	112	119	149	157	159	158	180
CWIP	1	4	8	2	1	1	14	3
Investments	289	239	274	259	274	291	284	294
Other Assets	89	88	127	186	180	169	221	234
Total Assets	488	442	528	597	612	620	676	711

THYROCARE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	97	136	111	106	120	155	179	206
Cash from Investing Activity	-3	27	-53	-12	-32	-80	-43	-21
Cash from Financing Activity	-96	-163	-58	-87	-88	-84	-124	-167
Net Cash Flow	-3	1	0	6	1	-9	12	18
Free Cash Flow	78	127	77	66	99	114	144	191
CFO/OP	107%	108%	91%	70%	129%	135%	121%	104%

THYROCARE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	71.06%	71.06%	71.06%	71.06%	60.93%	60.92%	60.92%	51.02%
FIIs	2.77%	2.41%	3.23%	4.85%	4.96%	5.37%	5.43%	9.37%
DIIs	14.68%	14.97%	14.54%	13.47%	20.52%	21.00%	20.92%	25.92%
Public	11.49%	11.57%	11.18%	10.61%	13.61%	12.71%	12.71%	13.69%
No. of Shareholders	56,666	57,403	54,566	54,142	77,619	73,377	73,064	75,186

THYROCARE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	11	14	34	60	63	28	40	33
Inventory Days	54	60	50	54	63	106	93	81
Days Payable	19	62	48	30	52	83	141	96
Cash Conversion Cycle	46	12	37	84	74	51	-9	18
Working Capital Days	4	-12	7	45	34	14	18	24
ROCE %	31%	36%	37%	41%	15%	18%	26%	36%

THYROCAREUpdated 14 Oct 2026, 23:23

Thyrocare Tech Ltd

THYROCAREUpdated 14 Oct 2026, 23:23

Market Cap

₹7,852Cr.

Current Price

₹494

High / Low

₹662/343

Stock P/E

47.0

ROE26.8%

ROCE36.1%

Book Value₹35.2

Face Value₹10.0

Dividend Yield1.89%

About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	124	1	90	0	9	24	31	17	1.05
Sep 2023	136	1	100	2	9	28	28	20	1.28
Dec 2023	123	1	92	2	11	21	28	15	0.94
Mar 2024	141	1	108	3	10	25	23	19	1.21
Jun 2024	144	1	101	3	9	35	28	25	1.58
Sep 2024	163	1	114	2	10	40	27	30	1.86
Dec 2024	153	0	112	4	15	28	32	19	1.2
Mar 2025	174	1	118	5	12	48	54	22	1.38
Jun 2025	179	1	122	4	9	51	29	36	2.27
Sep 2025	202	1	133	2	10	61	29	43	2.71
Dec 2025	182	0	124	-3	20	37	29	26	1.64
Mar 2026	211	1	138	4	13	62	30	44	2.74
Jun 2026	226	1	150	4	11	67	25	50	3.15

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	180	0	109	13	11	73	33	49	3.25
Mar 2016	235	1	140	6	11	89	34	59	3.64
Mar 2017	298	0	182	-16	12	87	46	47	2.9
Mar 2018	332	0	193	21	12	148	35	96	5.96
Mar 2019	370	0	222	14	14	147	35	95	6.01
Mar 2020	401	1	233	-35	20	112	29	79	5
Mar 2021	474	1	304	12	21	161	26	120	7.55
Mar 2022	562	3	330	7	28	207	27	152	9.58
Mar 2023	486	5	371	5	34	81	30	57	3.59
Mar 2024	524	5	388	6	39	98	28	71	4.48
Mar 2025	633	3	446	13	47	151	37	96	6.02
Mar 2026	774	3	517	7	51	210	29	149	9.35
TTM	821	3	546	7	53	226	—	163	10.24

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	51.02%
FIIs	9.37%
DIIs	25.92%
Public	13.69%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public	Others
Dec 2023	71.11%	3.35%	13.89%	11.64%	—
Mar 2024	71.11%	2.9%	14.88%	11.11%	—
Jun 2024	71.11%	2.49%	14.89%	11.49%	—
Sep 2024	71.11%	1.93%	14.79%	12.15%	—
Dec 2024	71.06%	2.77%	14.68%	11.49%	—
Mar 2025	71.06%	2.41%	14.97%	11.57%	—
Jun 2025	71.06%	3.23%	14.54%	11.18%	—
Sep 2025	71.06%	4.85%	13.47%	10.61%	—
Dec 2025	60.93%	4.96%	20.52%	13.61%	—
Mar 2026	60.92%	5.37%	21%	12.71%	—
Jun 2026	60.92%	5.43%	20.92%	12.71%	—
Sep 2026	51.02%	9.37%	25.92%	13.69%	—

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	51	229	0	14	293	83	6	162	42	293
Mar 2016	54	322	0	39	414	93	1	266	55	414
Mar 2017	54	364	0	26	444	89	2	299	54	444
Mar 2018	54	400	0	31	485	103	0	315	68	485
Mar 2019	53	403	0	32	488	108	1	289	89	488
Mar 2020	53	325	9	55	442	112	4	239	88	442
Mar 2021	53	393	10	73	528	119	8	274	127	528
Mar 2022	53	468	21	55	597	149	2	259	186	597
Mar 2023	53	468	21	70	612	157	1	274	180	612
Mar 2024	53	461	39	68	620	159	1	291	169	620
Mar 2025	53	484	23	116	676	158	14	284	221	676
Mar 2026	159	402	48	102	711	180	3	294	234	711

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	36	-21	-23	-7
Mar 2016	67	-19	-45	3
Mar 2017	89	-40	-48	1
Mar 2018	112	-48	-65	-1
Mar 2019	97	-3	-96	-3
Mar 2020	136	27	-163	1
Mar 2021	111	-53	-58	0
Mar 2022	106	-12	-87	6
Mar 2023	120	-32	-88	1
Mar 2024	155	-80	-84	-9
Mar 2025	179	-43	-124	12
Mar 2026	206	-21	-167	18

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	9	11	7	10	11	14	34	60	63	28	40	33
Inventory Days	47	54	64	66	54	60	50	54	63	106	93	81
Days Payable	5	8	4	23	19	62	48	30	52	83	141	96
Cash Conversion Cycle	51	57	68	53	46	12	37	84	74	51	-9	18
Working Capital Days	52	15	28	11	4	-12	7	45	34	14	18	24
ROCE %	27%	27%	29%	33%	31%	36%	37%	41%	15%	18%	26%	36%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of THYROCARE TECH LTD (THYROCARE)?

The reported market capitalisation for THYROCARE TECH LTD (THYROCARE) is ₹7,852Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of THYROCARE?

The current price shown for THYROCARE TECH LTD (THYROCARE) on Fincrux is ₹494 with a 52-week high/low of ₹662/343.

What is the P/E ratio of THYROCARE TECH LTD (THYROCARE)?

The stock P/E for THYROCARE TECH LTD (THYROCARE) is 47.0 on Fincrux, with ROE at 26.8% and ROCE at 36.1%.

What were THYROCARE latest quarterly results?

For Jun 2026, THYROCARE TECH LTD (THYROCARE) reported sales ₹226 Cr and net profit ₹50 Cr (figures in ₹ crore unless noted).

What are THYROCARE annual sales and net profit?

For TTM, THYROCARE TECH LTD (THYROCARE) shows sales of ₹821 Cr and net profit of ₹163 Cr on the Fincrux profit & loss statement.

Who owns THYROCARE TECH LTD (THYROCARE)?

Latest shareholding for THYROCARE TECH LTD (THYROCARE) on Fincrux: Promoters 51.02% (Sep 2026), FIIs 9.37% (Sep 2026), DIIs 25.92% (Sep 2026), Public 13.69% (Sep 2026), No. of Shareholders 75,186% (Sep 2026).

Where can I find THYROCARE TECH LTD (THYROCARE) financials?

THYROCARE TECH LTD (THYROCARE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show THYROCARE balance sheet and cash flow?

Yes. The THYROCARE TECH LTD (THYROCARE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 14 October 2026 at 23:23